CRW
GOODCraneware Delivers Strong H1 FY26 Performance Amid Challenges
The healthcare technology company reported strong first-half results, with double-digit EBITDA growth and healthy revenue expansion, despite facing some market challenges.
Craneware
1,835.00GBX
-2.65%
Market Cap
651.59M
Volume
320.13k
411% of avg
P/E Ratio
1846.20
EPS (TTM)
0.99
Beta
-0.27
Day Range
1,700.00p - 1,850.00p
52 Week Range
1,495.00p1,835.00p2,644.00p
1,835.00p
Upcoming Events
2 March 2026
Announcement of results for the six months ended 31 December 2025
High Impact Event
30 June 2028
Final tranche of LTIP awards vesting
CRW
NEUTRALCraneware Provides AGM Update and Announces Board Changes
The healthcare technology company provides a trading update ahead of its AGM and announces board changes, including the retirement of a long-serving non-executive director.
CRW
NEUTRALCraneware Announces Effective Date of Reduction of Capital
The healthcare technology company announces the effective date of its Reduction of Capital, creating additional distributable reserves.
CRW
NEUTRALCraneware Confirms Reduction of Capital
The healthcare software company has confirmed a Reduction of Capital that will create additional distributable reserves.
CRW
NEUTRALCraneware Releases Annual Report, Announces AGM and Directorate Change
The healthcare technology company has released its annual report and announced its upcoming AGM, as well as a change to its board of directors.
CRW
NEUTRALCraneware Grants Long-Term Incentive Awards to Directors and PDMR
The healthcare technology company has granted long-term incentive plan awards to key executives, aligning their interests with shareholders.
CRW
GOODCraneware Reports Strong FY25 Results with 52% Profit Growth
The healthcare financial performance solutions provider reported a 52% profit increase and 9% revenue growth. Strong recurring revenue and customer retention underpin the positive results.
CRW
GOODCraneware Secures Improved Bank Financing to Support Growth Strategy
The healthcare technology company has secured a new bank financing facility, providing increased flexibility to support its growth strategy.
CRW
NEUTRALCraneware Proposes Reduction of Capital
The healthcare technology company is proposing a reduction of capital to create distributable reserves and provide more flexibility for shareholder returns.
CRW
VERY GOODCraneware Delivers Strong FY25 Performance, Exceeding Expectations
The healthcare technology company reported strong financial results, with double-digit growth in EBITDA and accelerating recurring revenue metrics, positioning it for continued success.